Cargando…
Helquat dyes targeting G-quadruplexes as a new class of anti-HIV-1 inhibitors
The secondary structure of nucleic acids containing quartets of guanines, termed G-quadruplexes, is known to regulate the transcription of many genes. Several G-quadruplexes can be formed in the HIV-1 long terminal repeat promoter region and their stabilization results in the inhibition of HIV-1 rep...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102027/ https://www.ncbi.nlm.nih.gov/pubmed/37055553 http://dx.doi.org/10.1038/s41598-023-33263-3 |
_version_ | 1785025614516846592 |
---|---|
author | Pávová, Marcela Reyes-Gutiérrez, Paul Eduardo Kozák, Jaroslav Dobiaš, Juraj Yurenko, Yevgen Lepšík, Martin Teplý, Filip Weber, Jan |
author_facet | Pávová, Marcela Reyes-Gutiérrez, Paul Eduardo Kozák, Jaroslav Dobiaš, Juraj Yurenko, Yevgen Lepšík, Martin Teplý, Filip Weber, Jan |
author_sort | Pávová, Marcela |
collection | PubMed |
description | The secondary structure of nucleic acids containing quartets of guanines, termed G-quadruplexes, is known to regulate the transcription of many genes. Several G-quadruplexes can be formed in the HIV-1 long terminal repeat promoter region and their stabilization results in the inhibition of HIV-1 replication. Here, we identified helquat-based compounds as a new class of anti-HIV-1 inhibitors that inhibit HIV-1 replication at the stage of reverse transcription and provirus expression. Using Taq polymerase stop and FRET melting assays, we have demonstrated their ability to stabilize G-quadruplexes in the HIV-1 long-terminal repeat sequence. Moreover, these compounds were not binding to the general G-rich region, but rather to G-quadruplex-forming regions. Finally, docking and molecular dynamics calculations indicate that the structure of the helquat core greatly affects the binding mode to the individual G-quadruplexes. Our findings can provide useful information for the further rational design of inhibitors targeting G-quadruplexes in HIV-1. |
format | Online Article Text |
id | pubmed-10102027 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-101020272023-04-15 Helquat dyes targeting G-quadruplexes as a new class of anti-HIV-1 inhibitors Pávová, Marcela Reyes-Gutiérrez, Paul Eduardo Kozák, Jaroslav Dobiaš, Juraj Yurenko, Yevgen Lepšík, Martin Teplý, Filip Weber, Jan Sci Rep Article The secondary structure of nucleic acids containing quartets of guanines, termed G-quadruplexes, is known to regulate the transcription of many genes. Several G-quadruplexes can be formed in the HIV-1 long terminal repeat promoter region and their stabilization results in the inhibition of HIV-1 replication. Here, we identified helquat-based compounds as a new class of anti-HIV-1 inhibitors that inhibit HIV-1 replication at the stage of reverse transcription and provirus expression. Using Taq polymerase stop and FRET melting assays, we have demonstrated their ability to stabilize G-quadruplexes in the HIV-1 long-terminal repeat sequence. Moreover, these compounds were not binding to the general G-rich region, but rather to G-quadruplex-forming regions. Finally, docking and molecular dynamics calculations indicate that the structure of the helquat core greatly affects the binding mode to the individual G-quadruplexes. Our findings can provide useful information for the further rational design of inhibitors targeting G-quadruplexes in HIV-1. Nature Publishing Group UK 2023-04-13 /pmc/articles/PMC10102027/ /pubmed/37055553 http://dx.doi.org/10.1038/s41598-023-33263-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Pávová, Marcela Reyes-Gutiérrez, Paul Eduardo Kozák, Jaroslav Dobiaš, Juraj Yurenko, Yevgen Lepšík, Martin Teplý, Filip Weber, Jan Helquat dyes targeting G-quadruplexes as a new class of anti-HIV-1 inhibitors |
title | Helquat dyes targeting G-quadruplexes as a new class of anti-HIV-1 inhibitors |
title_full | Helquat dyes targeting G-quadruplexes as a new class of anti-HIV-1 inhibitors |
title_fullStr | Helquat dyes targeting G-quadruplexes as a new class of anti-HIV-1 inhibitors |
title_full_unstemmed | Helquat dyes targeting G-quadruplexes as a new class of anti-HIV-1 inhibitors |
title_short | Helquat dyes targeting G-quadruplexes as a new class of anti-HIV-1 inhibitors |
title_sort | helquat dyes targeting g-quadruplexes as a new class of anti-hiv-1 inhibitors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102027/ https://www.ncbi.nlm.nih.gov/pubmed/37055553 http://dx.doi.org/10.1038/s41598-023-33263-3 |
work_keys_str_mv | AT pavovamarcela helquatdyestargetinggquadruplexesasanewclassofantihiv1inhibitors AT reyesgutierrezpauleduardo helquatdyestargetinggquadruplexesasanewclassofantihiv1inhibitors AT kozakjaroslav helquatdyestargetinggquadruplexesasanewclassofantihiv1inhibitors AT dobiasjuraj helquatdyestargetinggquadruplexesasanewclassofantihiv1inhibitors AT yurenkoyevgen helquatdyestargetinggquadruplexesasanewclassofantihiv1inhibitors AT lepsikmartin helquatdyestargetinggquadruplexesasanewclassofantihiv1inhibitors AT teplyfilip helquatdyestargetinggquadruplexesasanewclassofantihiv1inhibitors AT weberjan helquatdyestargetinggquadruplexesasanewclassofantihiv1inhibitors |